LifeMD, Inc. — Director's Dealing 2023

Nov 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-11-06

Reporting Person: Jindal Piyush (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-06	Common Stock	M	37500	$2.52	Acquired	337500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-06	Stock Option (Right to Buy)	$2.52	M	37500	Disposed		Common Stock (37500)	Direct

Footnotes

F1: The options vested in four equal installments at 90, 180, 270 and 365 days from September 14, 2022, the date of grant. The option expires on September 14, 2027.